Cytokinetics
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Mission:?We are developing potential medicines to improve the healthspan of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
51 to 200 Employees
TypeCompany - Public
RevenueUnknown / Non-Applicable
IndustryBiotech & Pharmaceuticals
CompetitorsIonis Pharmaceuticals, MyoKardia, PTC Therapeutics
Founded1997
Share Profile
-
ManagerWorked since -
-
President and ChairmanWorked since -
-
New York, NYCompany size: 51 to 200 -
London, England (UK)Company size: 51 to 200 -
Carlsbad, CACompany size: 1 to 50 -
Washington, DCCompany size: 201 to 500 -
New York, NYCompany size: 1 to 50 -
Fort Lauderdale, Florida, United StatesCompany size: 21,600
